Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine 2000 March;44(1)

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1)

 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):1-2

Foreword

Bombardieri E.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):3-12

State of the art and future prospects in the management of neuroendocrine tumors

Öberg K.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):13-21

Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract

Rindi G., Capella C. *, Solcia E. **


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):22-41

Laboratory tests for neuroendocrine tumours

Seregni E., Ferrari L., Stivanello M. *, Dogliotti L. *


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):42-49

Results and potential of somatostatin receptor imaging in gastroenteropancreatic tract tumours

Chiti A., Briganti V. *, Fanti S. **, Monetti N. **, Masi R. *, Bombardieri E.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):50-8

New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy

Virgolini I., Traub T., Leimer M., Novotny C., Pangerl T., Ofluoglu S., Halvadjieva E., Smith- Jones P., Flores J., Li S. R., Angelberger P., Havlik E., Andreae F., Raderer M., Kurtaran A., Niederle B., Dudczak R.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):59-67

Intraoperative use of gamma-detecting probes to localize neuroendocrine tumors

Adams S., Baum R. P. *


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):68-76

Use of PET in neuroendocrine tumors. In vivo applications and in vitro studies

Eriksson B., Bergström M. *, Örlefors H., Sundin A. *,**, Öberg K., Långström B. *


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):77-87

Role of 131I-metaiodobenzylguanidine (MIBG) in the treatment of neuroendocrine tumours. Experience of the National Cancer Institute of Milan

Castellani M. R., Chiti A., Seregni E., Bombardieri E.


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):88-95

In situ radiotherapy with 111In-pentetreotide. State of the art and perspectives

McCarthy K. E., Woltering E. A. *, Anthony L. B. **


 NEUROENDOCRINE TUMORS
Guest Editors: Bombardieri E. 

The Quarterly Journal of Nuclear Medicine 2000 March;44(1):96-101

New clinical trials for the treatment of neuroendocrine tumors

Bajetta E., Bichisao E. *, Artale S., Celio L., Ferrari L., Di Bartolomeo M., Zilembo N., Stani S. C., Buzzoni R.


top of page